Skip to main content

Thank you for your interest in helping AADPA to grow by being involved in one of the new sub-committees.


A brief description of each new sub-committee is below. Expressions of interest are now invited via the EOI form on this page until midnight AEST on Sunday, 14 May 2023. 

Guideline Committee

This Committee will be drawn from the Panel that has shepherded the development of the Guideline to ensure continuity during the launch phase and will transition in 2023 to a broader membership.

Research Committee

To develop a forward-thinking research strategy for AADPA based on need, leveraging the Guidelines, opportunities for next-generation researchers and opportunities to lead or partner on grants.

Finance & Audit Committee

A new Director will lead this Committee that will develop a strategy for AADPA to have better funding and revenue certainty. It will also be responsible for overseeing the organisation’s reporting requirements.

Education & Training Committee

To develop and consider initiatives that will advance professional development for members, consider micro-credentialing revenue pathways and other fee-paying training programs. Also includes forging relationships with academic institutions that could develop curricula to train the next generation of clinicians better.

Advocacy Panel

This Panel will work on initiatives that promote better policy, such as a national standardised guideline for prescribing stimulant medication and models of care. It will also include partnering with consumer and community groups on campaigns and programs to advance better understanding and acceptance of ADHD.

Expression of Interest Form

Thank you for your interest, Expressions of Interest for AADPA's Sub-Committee Groups have now closed.